Headwaters Capital Management, an investment management company, released its fourth-quarter 2024 investor letter. A copy of ...
NEW YORK CITY, NY / ACCESS Newswire / January 22, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims ...
TransMedics Gr TMDX has outperformed the market over the past 5 years by 12.34% on an annualized basis producing an average ...
TransMedics' stock remains under pressure after a weak third quarter, reduced Q4 guidance, the exit of the company's CFO, and ...
TransMedics Group, Inc. TMDX recently issued a statement refuting the claims made in a report by short-seller Scorpion Capital on Jan. 10, 2025, stating them as inaccurate and misleading.
JP Morgan has recently reduced TransMedics Group Inc (TMDX) stock to Neutral rating, as announced on December 17, 2024, according to Finviz. Earlier, on November 22, 2024, Needham had reduced the ...
January 18, 2025, 05:16 am ET, BY Momei- Contributor, Stock Traders Daily| Editor: Thomas H. Kee Jr. ( Follow on LinkedIn) ...
Zacks.com on MSN3d
TMDX Stock Plunges 49.2% in Three Months: What's Behind the Downfall?TransMedics is navigating macroeconomic challenges amid its focus on meaningful progress across each of its growth initiatives.
TMDX was the top contributor in Q2 (and I trimmed the position at that time given stretched valuation). Fast forward to Q4 and the narrative around this company has completely changed.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback